| NQVAX | VEVYX | NQVAX / VEVYX | |
| Total Expense Ratio | 1.15 | 0.66 | 174% |
| Annual Report Gross Expense Ratio | 1.22 | 0.66 | 185% |
| Fund Existence | 23 years | 13 years | - |
| Gain YTD | 18.531 | 4.348 | 426% |
| Front Load | 6% | N/A | - |
| Min. Initial Investment | 2500 | 1000000 | 0% |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 861M | 16.1B | 5% |
| Annual Yield % from dividends | 1.12 | 1.02 | 109% |
| Returns for 1 year | 14.29 | -9.26 | -154% |
| Returns for 3 years | 58.44 | 1.31 | 4,472% |
| Returns for 5 years | 109.84 | 21.59 | 509% |
| Returns for 10 years | 204.65 | 58.93 | 347% |
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| IVOG | 124.26 | 1.24 | +1.01% |
| Vanguard S&P Mid-Cap 400 Growth ETF | |||
| STXK | 34.46 | 0.16 | +0.47% |
| Strive Small-Cap ETF | |||
| PFFV | 22.57 | 0.07 | +0.31% |
| Global X Variable Rate Preferred ETF | |||
| MUNY | 103.18 | 0.06 | +0.05% |
| Vanguard New York Tx-Exm Bd ETF | |||
| MGRO | 32.21 | N/A | N/A |
| VanEck Morningstar Wide Moat Growth ETF | |||